HIF‐1α and HIF‐2α have divergent roles in colon cancer
Takaaki Imamura(Massachusetts General Hospital), Daniel C. Chung(Massachusetts General Hospital), Ramnik J. Xavier(Massachusetts General Hospital), Hirotoshi Kikuchi(Massachusetts General Hospital), Bo R. Rueda(Harvard University), Mari Mino‐Kenduson(Massachusetts General Hospital), Maureen P. Lynch(Harvard University), Yusuke Mizukami(Asahikawa Medical College Hospital), Do‐Youn Park(Massachusetts General Hospital), Yair Benita(Massachusetts General Hospital)
Cited by 157
Related Papers
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
|Cell Host & Microbe|2014|3.3k
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
|Genome biology|2012|2.8k
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k
Defining trained immunity and its role in health and disease
|Nature reviews. Immunology|2020|2.5k